Glenmark Pharmaceuticals Limited has informed the Exchange about Transcript
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has informed the stock exchanges that the transcript of its Q1 FY26 earnings call (quarter ended June 30, 2025), held on August 18, 2025, has been uploaded on the company's website. This is a routine compliance filing under SEBI LODR Regulation 30(6). The transcript is available via a PDF link on Glenmark's investor relations page. No financial figures, guidance, or management commentary is included in this particular filing — it only serves as a notice of upload.
No direct impact on stock price. Investors who want management's views on Q1 performance, margins, debt, or outlook should read the actual earnings call transcript linked in the filing.